WRBY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
WRBY is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 who does not want to wait for a better entry. The stock has meaningful long-term story potential from smart glasses and continued core business growth, but the current technical setup is weak and the valuation/launch upside is still too dependent on execution. My direct view: hold for now, not a buy today.
Current price is 22.35 after a sharp -7.34% regular-session drop, with only a small +1.04% pre-market bounce. The trend is still fragile: MACD histogram is -0.441 and expanding negatively, which confirms bearish momentum. RSI_6 at 22.774 suggests the stock is oversold or near-oversold, but it has not yet produced a strong reversal signal. Moving averages are converging, which can sometimes precede a move, but there is no confirmed bullish breakout. Price is below the pivot at 24.603 and sitting near S1 at 22.919, with S2 at 21.878 as the next support. Overall, the chart favors caution, not immediate entry.
The main positive catalyst is Warby Parker’s smart glasses initiative, especially the announced first intelligent eyewear frame and the expected fall 2026 launch. Analysts from BTIG and Piper Sandler remain constructive, and Telsey noted a solid Q1 with better-than-expected revenue growth, tighter expense control, and improving customer metrics. UBS also cited strong net sales growth, higher average revenue per customer, and encouraging early interest in smart glasses. The product pipeline could support a multi-quarter re-rating if execution and launch clarity improve.
There has been no news in the last week, so near-term momentum is lacking. The recent share drop followed disappointment over limited details on pricing, timing, hardware specs, and launch structure for the smart eyewear product. Technically the stock is still under pressure, and the market appears unconvinced that the new product will create immediate financial impact. The broader market was also weak with the S&P 500 down 1.81%, which adds pressure to growth names.
The latest quarter available is Q1 FY26, and the company showed solid operating progress. Revenue growth was better than expected at 8.3% year over year, average revenue per customer rose 6.9%, and management commentary pointed to improving Q2 trends. Analysts also highlighted tighter expense control and a bottom-line beat, although gross margin deleverage remained a headwind. Overall, the latest quarter was healthy, but not strong enough to justify an aggressive immediate buy purely on fundamentals.
Analyst sentiment is mixed but leaning constructive. Recent calls include Stifel at Hold, BTIG at Buy, Piper Sandler at Overweight with a $32 target, UBS at Neutral with a $27 target, Telsey at Outperform with a raised $33 target, and Citi at Neutral with a $24 target. The trend in targets has been upward, which is positive, but the split ratings show Wall Street is still divided. The pros see growth in customers, revenue, and smart glasses optionality; the cons focus on unclear launch economics, limited detail, and uncertainty about how much the AI eyewear can contribute in fiscal 2027.
